Yale University

Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

TitleClinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.
Publication TypeJournal Article
Year of Publication2008
AuthorsMaru, Duncan Smith-Rohrberg, Robert Douglas Bruce, Sanjay Basu, and Frederick L. Altice
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume47
Issue7
Pagination952-61
Date Published2008 Oct 1
ISSN1537-6591
KeywordsAdult, Antiviral Agents, Drug Therapy, Combination, Female, Hepatitis C, Humans, Interferon-alpha, Longitudinal Studies, Male, Middle Aged, Polyethylene Glycols, Prisoners, Prisons, Recombinant Proteins, Retrospective Studies, Ribavirin
AbstractMore than one-third of people in the United States with hepatic C virus (HCV) infection pass through the correctional system annually. Data are lacking on outcomes of treatment with pegylated interferon plus ribavirin (PEG-RBV) in correctional settings.
DOI10.1086/591707
Alternate JournalClin. Infect. Dis.

External Links